Dermatology 2013

Notes: Rathod, Suvarna S

Motghare, Vijay M

Deshmukh, Vinod S

Deshpande, Rushikesh P

Bhamare, Chetanraj G

Patil, Jyoti R

eng

India

2013/10/02 06:00

Indian J Dermatol. 2013 Sep;58(5):342-5. doi: 10.4103/0019-5154.117293.

URL: http://www.ncbi.nlm.nih.gov/pubmed/24082175

Author Address: Department of Pharmacology, S.R.T.R. Medical College, Ambajogai, Beed, Maharashtra, India.

 

 

Reference Type:  Journal Article

Record Number: 4252Author: Reddi, A., Prescott, L., Doney, E., Delamere, F., Kollipara, R., Dellavalle, R. P. and Williams, H. C.

Year: 2013

Title: The Cochrane Skin Group: a vanguard for developing and promoting evidence-based dermatology

Journal: J Evid Based Med

Volume: 6

Issue: 4

Pages: 236-42

Date: Nov

Short Title: The Cochrane Skin Group: a vanguard for developing and promoting evidence-based dermatology

Alternate Journal: Journal of evidence-based medicine

ISSN: 1756-5391 (Electronic)

1756-5391 (Linking)

DOI: 10.1111/jebm.12068

PMCID: 4163638

Accession Number: 24325417

Keywords: *Evidence-Based Medicine

Humans

Information Dissemination

*Organizations, Nonprofit

Practice Guidelines as Topic

*Review Literature as Topic

Skin Diseases/*therapy

Abstract: AIM: The Cochrane Skin Group (CSG) is part of the international Cochrane Collaboration (http://www.cochrane.org/). The CSG prepares, maintains and disseminates high quality evidence-based summaries on the prevention, diagnosis and treatment of skin diseases. We present a synopsis of the history, scope and priorities of the CSG. In addition, we report outcomes of CSG reviews and critically assess clinical value. METHODS: Descriptive analysis of systematic reviews published by the CSG since its inception including output, impact factor, associated methodological studies, and influence in clinical guidelines, promoting patient and public engagement and in triggering new primary research. RESULTS: The CSG started in 1997, and has published 61 reviews, 34 protocols and 31 registered titles by August 2013. The CSG scope includes 1000 skin diseases; 80% of reviews cover the top ten diagnoses and 40% of reviews provide clear guidance for clinical practice. CSG reviews had an impact factor of 6.1 in 2011 which places it alongside top dermatology journals. CSG reviews are typically broad in focus and have been shown to be of better quality than non-Cochrane reviews. They are highly cited in clinical guidelines. Several reviews have identified evidence gaps that have led to better primary research. CONCLUSIONS: The CSG has emerged as a vanguard of evidence-based dermatology by growing a community interested in applying best external evidence to the care of skin patients and by identifying topics for research. CSG reviews are high impact, clinically relevant and have tangibly influenced international dermatology clinical practice guidelines and new research.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295